Half-Yearly Gainers: $KOPN $AWH $NEON

*If You Own KOPN, AWH, NEON Then Click Here to Join Our Community Of Traders

The Market Signal was created as a platform to help investors, if you own (NASDAQ:KOPN), (NASDAQ:AWH) or (NASDAQ:NEON) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Kopin Corporation looks bullish after announcing significant breakthrough in the development of its Dual-Stack OLED Micro Displays

https://themarketsignal.com/Free-Report/KOPN

(Click link above or copy, paste and hit enter in your browser for your report)

Kopin Corporation (NASDAQ:KOPN) has gained 325.75% over the past six months.

The company has announced significant breakthrough in the development of its Dual-Stack OLED Micro Displays. Kopin also shipped its first production order of OLED Backplane Wafers ajnd received follow-on orders.

2Q 2020 2Q 2019 Product revenues $6.7 million $4.4 million Funded research, development and other revenue $2.1 million $4.7 million Total revenues $8.8 million $9.1 million Research and development $2.2 million $3.3 million Selling, general and administrative $2.9 million $5.4 million Net Loss $1.1 million $4.3 million CFO $2.9 million Cash And Equivalents And Marketable Securities $15.3 million

Another promising stock is Aspira Women's Health having gained 376.41% over the past six months

https://themarketsignal.com/Free-Report/AWH

(Click link above or copy, paste and hit enter in your browser for your report)

Aspira Women's Health Inc (NASDAQ:AWH) has gained 376.41% over the past six months. During the second quarter of 2020, the company reported an 18% drop in total number of customers compared to the second quarter of 2019. Aspira's new customers also went down by 56% compared to 2Q 2019.

In the 2Q 2020, the company rolled out COVID-19 antibody testing and started plans to start offering COVID-19 antigen testing. Aspira says each test will part of its pre-surgical risk test offering and will include additional tumor proteins, OVA1plus test, and genetics.

The company recently announced completing laboratory validations for its antibody test and several additional oncology biomarkers. In the June 10th announcement, the company said that it would offer the Roche Elecsys Anti-SARS-Co-V-2 Assay, which has 100% specificity and 99.8% sensitivity. Aspira also noted it has postponed the planned offering of COVID-19 antigen testing due to manufacturer instrumentation delays. The test will be offered in late third quarter or early fourth quarter 2020.

2Q 2020 2Q 2019 Revenue on a per test performed basis for OVA1 revenue $295 OVA1 tests 2,458 3,129 Gross profit on OVA1 product revenue $268000 $491000 Research and development expenses $380000 $225000 Sales and marketing expenses $1.7M $2.8M General and administrative expenses $1.9M $1.5M Cash Balance $10.9 million

Neonode looking bullish after securing deal to install contactless self-check in kiosks at Singapore Changi Airport

https://themarketsignal.com/Free-Report/NEON

(Click link above or copy, paste and hit enter in your browser for your report)
Neonode, Inc (NASDAQ:NEON) has gained 248.25% over the past six months. The company has partnered with Singapore Changi Airport to offer contactless self-check in kiosks powered by Neonode zForce(R) technology. The technology uses happyhover(TM), a retrofit solution developed by Singapore-based Arctan Analytics Pte Ltd.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_369413469/2705/2020-08-14T08:08:18

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.